Morgan Stanley Has Lowered Expectations for Illumina (NASDAQ:ILMN) Stock Price

Illumina (NASDAQ:ILMN – Free Report) had its price objective decreased by Morgan Stanley from $156.00 to $150.00 in a research note published on Monday,Benzinga reports. Morgan Stanley currently has an equal weight rating on the life sciences company’s stock. Other equities analysts also recently issued reports about the stock. TD Cowen upped their target price […]

Leave a Reply

Your email address will not be published.

Previous post Insider Buying: Alaris Equity Partners Income Trust (AD.UN) (TSE:AD.UN) Director Acquires C$91,285.00 in Stock
Next post Rostislav Christov Raykov Buys 19,200 Shares of Lavras Gold Corp. (CVE:LGC) Stock